Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial

BACKGROUND: The efficacy of topical minoxidil (MX) alone on female pattern hair loss (FPHL) is limited. Combination therapy based on topical MX is currently expected to provide better outcomes. OBJECTIVES: This study aimed to assess whether the combined therapies including MX plus oral spironolacton...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xuelei, Chang, Yuan, Wu, Haixuan, Liu, Yi, Zhao, Jian, Wang, Leyi, Zhuo, Fenglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309533/
https://www.ncbi.nlm.nih.gov/pubmed/35899211
http://dx.doi.org/10.3389/fmed.2022.905140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309533/
https://www.ncbi.nlm.nih.gov/pubmed/35899211
http://dx.doi.org/10.3389/fmed.2022.905140

Ejemplares similares